Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preventing Microalbuminuria in Type 2 Diabetes (VARIETY)

This study has been completed.
Sponsor:
Collaborator:
Agenzia Italiana del Farmaco
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research
ClinicalTrials.gov Identifier:
NCT00503152
First received: July 17, 2007
Last updated: September 15, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2016
  Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)